Finally, the significance of SOX2 as a prognostic biomarker in HNSCC patients remains unclear, as the currently published studies are contradictory, although the majority of these studies reported high SOX2 expression levels as an adverse prognostic factor in this tumor [50]. The gene discussed is SOX2; the disease is head and neck squamous cell carcinoma.